Unknowns Remain Regarding Part D Senior Savings Model

Months after the Part D Senior Savings Model was unveiled, the Trump administration on May 26 held a press conference in the White House Rose Garden to share what reporters and industry observers hoped would be more information about the new benefit that will be available to seniors next year. But the few details that were disclosed regarding participation raised only more questions about the potential success of the model, experts suggest.

CMS on May 26 said 88 Part D sponsors have applied to offer enhanced plans with predictable cost sharing on insulin as part of the Part D Senior Savings Model. Introduced through the CMS Innovation Center in March, the five-year model is intended to lower out-of-pocket costs for diabetic seniors by featuring “predictable” copayments of no more than $35 for a broad set of insulins beginning in 2021 (RMA 3/19/20, p. 1).

© 2023 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

congressional-building
June 1

‘Devil Will Be in the Details’ of Forthcoming Medicare-Medicaid Duals Bill

READ MORE
bills-and-pills
June 1

Proposed Rule Targets PBMs’ Medicaid Practices, Creates Pharma Pricing Audit

READ MORE
unitedhealthcare
June 1

National Carriers Net 80% of 500,000 MA Sign-Ups During Open Enrollment Period

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today